Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for active hand osteoarthritis
ACTRN12612000791831Phase 3Completed
- Sponsor
- University of Tasmania
- Start
- Jul 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adalimumab in hand osteoarthritis (2 arms), sponsored by University of Tasmania. Primary endpoint: Pain at 3 months. Started Jul 2013; status: completed.
02
Drugs
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on ACTRN12612000791831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000791831.